Cargando…
Therapy-related acute myeloid leukemia: A case series
Patients with primary cancer receiving chemotherapy and/or radiotherapy may develop therapy-related acute leukemia (t-AL). Therapy-related acute myeloid leukemia (t-AML) accounts for the majority of these cases and is frequently associated with a variety of cytogenetic and molecular abnormalities. T...
Autores principales: | Yang, Jie, Chen, Baoan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019864/ https://www.ncbi.nlm.nih.gov/pubmed/35497938 http://dx.doi.org/10.3892/ol.2022.13291 |
Ejemplares similares
-
Advances in the drug therapies of acute myeloid leukemia (except acute wpromyelocytic leukemia)
por: Lin, Min, et al.
Publicado: (2018) -
Mechanisms of drug resistance in acute myeloid leukemia
por: Zhang, Jing, et al.
Publicado: (2019) -
Quizartinib (AC220): a promising option for acute myeloid leukemia
por: Zhou, Fang, et al.
Publicado: (2019) -
A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia
por: Shikdar, Sufana, et al.
Publicado: (2022) -
The role of dasatinib in the management of chronic myeloid leukemia
por: Chen, Runzhe, et al.
Publicado: (2015)